Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial (Wellcome Open Research, 2020)

(untitled) - Marcovecchio, ML; Wicker, LS; Dunger, DB; Dutton, SJ; Kopijasz, S; Scudder, C; Todd, JA; Johnson, PRV